- Lobbying
- Lobbying by Corbus Pharmaceuticals Holdings, Inc
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Andrew Hawkins | Rep. Rogers, LA, Chief of Staff. |
Michael Woody | Rep. Berry, LA; Sen. Harkin, LA; Senate HELP Committee. |
Kelly Childress | Rep. Shimkus, LA; Rep. Rogers, Health Policy Adviser. |
David Mohler | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Drug Enforcement Administration (DEA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Drug Enforcement Administration (DEA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Drug Enforcement Administration (DEA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Drug Enforcement Administration (DEA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Drug Enforcement Administration (DEA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Drug Enforcement Administration (DEA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Drug Enforcement Administration (DEA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Drug Enforcement Administration (DEA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Drug Enforcement Administration (DEA)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues related to drug scheduling regulations at the Drug Enforcement Administration and Food Drug Administration..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate